SUMMARY A female patient is described with a single pancreatic tumour producing vasoactive intestiual polypeptide (VIP), insulin, and pancreatic polypeptide. The initial presentation was with diarrhoea and hypokalaemia and a raised plasma VIP was demonstrated. Her symptoms improved with metoclopramide administration and absolute concentrations of 28 aminoacid (peak IV) VIP were found to have fallen. She then developed hypoglycaemia with hyperinsulinism. All symptoms resolved after surgical excision. This case emphasises the potential of these tumours to contain more than one endocrine cell type synthesising different biologically active peptides. Received for publication 30 December 1980 found raised in many patients, including 77% of VIP-secreting tumours, but this is unassociated with known significant metabolic effects.13 Prostaglandin secretion'4 15 and calcitonin15 secretion is also recognised.
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Pancreatic endocrine tumours are associated with excessive secretion of insulin, gastrin, VIP,' glucagon,2 somatostatin,3 and pancreatic polypeptide.4 In 1965 Law et al.5 described a single metastatic islet cell tumour which was demonstrated to be producing gastrin, ACTH, and MSH.' Subsequently a number of case reports of single pancreatic endocrine tumours secreting multiple pancreatic polypeptide hormones have been described; these include combinations of gastrin and glucagon,6 insulin and gastrin,7 insulin and glucagon,5 and gastrin and VIP.9 A combination of VIP, glucagon, enteroglucagon, secretin, and serotonin is described.10 In a series of 35 pancreatic endocrine tumours, Broder and Carter found four tumours secreting two pancreatic hormones (insulin and gastrin in three cases and insulin and glucagon in one case) and one tumour secreting three hormones (insulin, gastrin, and glucagon Received for publication 30 December 1980 found raised in many patients, including 77% of VIP-secreting tumours, but this is unassociated with known significant metabolic effects.13 Prostaglandin secretion'4 15 and calcitonin15 secretion is also recognised.
In the above patients symptoms from one peptide hormone dominated but Hammar and Sale described an adult male with a more than 30 year history of the Zollinger-Ellison syndrome who then developed hypoglycaemia due to excessive insulin secretion by the tumour.'6 We report a lady with a tumour synthesising three peptides who initially presented with symptoms of VIP excess but who, after resolution of her diarrhoea, hypokalaemia, and plasma peak IV VIP immunoreactivity after metoclopramide administration, developed hypoglycaemia due to hyperinsulinism.
Methods
Plasma immunoreactive VIP,17 18 insulin,'9 and pancreatic polypeptide20 were measured by previously characterised specific radioimmunoassays. Fasting plasma was subjected to gel permeation chromatography. Samples (1 ml) were loaded onto a column of Sephadex G50 superfine (0.9x 60 cm) and eluted at a flow rate of 3 ml/h, at 505 4°C, with 0-06 mol/l sodium acetate pH 5.0 containing 0-2 mol/1 sodium chloride. Fractions (0.5 ml) were collected and assayed at two different dilutions to determine immunoreactive VIP content. The column was precalibrated with Dextran Blue, cytochrome C (M wt 12384), pure porcine VIP (M wt 3326), and Na'251 (M wt 148) as molecular size markers. The coloured markers and Nal25I were also included with each sample chromatogram as internal markers.
Three portions of the freshly excised tumour were frozen at -20°C for subsequent radioimmunoassay. The portions were weighed, boiled in distilled water, homogenised, and centrifuged. The supernatants were separated and the pellets homogenised again in 0.1 M formic acid, centrifuged, and the supernatants separated. All supernatants were then assayed for VIP and pancreatic polypeptide in duplicate in serial dilution. The mean of the peptide concentration of the three portions, which were closely similar, was taken as the concentration of peptide in the tumour. The insulin content could not be accurately measured, as it is unstable in the acid extraction technique used to solubilise the VIP and pancreatic polypeptide.
For immunocytochemistry tissue was frozen in arcton (freon) at -156°C and subsequently freeze-dried and vapour fixed in benzoquinone. Three gm serial paraffin sections were immunostained by the technique of indirect immunofluorescence using antibodies to insulin, VIP, and pancreatic polypeptide (for dilutions, see Table  1 ). For the simultaneous demonstration of two peptide hormones in the tissue, the double immunoperoxidase method using two different substrates, 4-Cl-1-napthol (blue product) and diamiobenzidine (brown product) was used.22 23 Ultrastructural studies were carried out using tissue fixed in 3% glutaraldehyde in 0.1 M phosphate buffer pH 7-2.
Case report A 48 year old white female secretary was admitted to the Hammersmith Hospital, London, in June 1979 with a 12 month history of profuse watery diarrhoea and the loss of 13 kg in weight to 44 kg. During the previous three months she had had about 20 bowel actions per 24 hours, waking almost hourly at night and with frequent faecal incontinence. For four weeks she had been anorexic and nauseated with intermittent vomiting and had complained of pain and weakness of the hands and calves.
She had a long history of extrinsic asthma and Long, Bryant, Yuille, Polak, and Bloom With diarrhoea the concentration of total immunoreactive VIP was 343 pmol/l and without diarrhoea 230 pmol/l. Gel chromatography of this plasma showed the presence of five peaks (Fig. 1) and the percentage VIP immunoreactivity in each of the peaks is shown in Table 2 . The recovery of total VIP-immunoreactivity loaded Fig. 1 Tu.mour cells reacted with antibodies to VIP, insulin (Fig. 3) , and pancreatic polypeptide, but cells staining for VIP and pancreatic polypeptide were relatively sparse. Both immunostaining of the serial sections and the double immunoperoxidase revealed a separate cellular origin for each * of the three regulatory peptides. Ultrastructural ' 4 studies showed the presence of an active and well-granulated tumour containing three types of -secretory granules (Fig. 4) : one large (200-220 nm) with a well-defined wide halo and core resembling insulin granules,24 another rather small (100-130 nm in diameter) corresponding to Fig 3 (a 
